February 17, 2022 article Open access Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme International Journal of Psychiatry in Clinical Practice DOI: 10.1080/13651501.2022.2030757 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 2 stored of 55 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Intranasal esketamine significantly alleviates depression severity and suicidal ideations in electroconvulsive therapy (ECT) non-responders 2025 European Archives of Psychiatry and Clinical Neuroscience article Medicine Treatment of Major Depression Open access 3 citations Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study 2022 Frontiers in Psychiatry article Medicine Treatment of Major Depression Open access 43 citations 2 results References 0